UNSPSC 51402001: Emylcamate

This classification denotes an anxiolytic with the molecular formula C7H15NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KCJ747D3R4, chemically known as 3-pentanol, 3-methyl-, carbamate (8ci)(9ci) but generally known as emylcamate, which bears US NIH Compound Identifier 6526. European Medicines Agency schedules Emylcamate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06512MIG.

UNSPSC 51402001 Emylcamate is a Commodity code with minimal recent state and local procurement activity. The source contains no solicitations explicitly seeking emylcamate or related pharmaceutical compounds; the three recent opportunities tagged to this code (Seminole County's naloxone and drug deactivation systems procurement, Texas HHS's direct-to-manufacturer prescription RFI, and MMCAP's generic pharmaceuticals cooperative purchasing RFP) address pharmaceutical supply, distribution, and pharmacy benefit management but do not specifically target emylcamate or align with the code's nominal scope.

The mismatch between the code and the actual solicitations suggests that either the opportunities were miscoded by the issuing jurisdictions or that emylcamate procurement has not generated recent state and local solicitations. No geographic concentration, issuing-body repeat buyers, or representative contracting patterns emerge for this code from the source material. Firms evaluating pursuit under this code should verify directly with issuing bodies whether active demand exists before investing in capability or compliance infrastructure.